[Tavegyl in the treatment of allergic diseases and neurovascular disorders of the nose].
D000293:Adolescent; D000328:Adult; D000368:Aged; D002648:Child; D005260:Female; D006634:Histamine H1 Antagonists / Q000009:adverse effects / Q000627:therapeutic use*; D006801:Humans; D008297:Male; D008875:Middle Aged; D011759:Pyrrolidines / Q000009:adverse effects / Q000627:therapeutic use*; D006255:Rhinitis, Allergic, Seasonal / Q000188:drug therapy*
D006634:Histamine H1 Antagonists; D011759:Pyrrolidines
Tavegyl in der Behandlung allergischer Erkrankungen und neurovaskulärer Störungen der Nase.